Adapting regulatory drug‐drug interaction guidance to design clinical pharmacokinetic natural product‐drug interaction studies: An NaPDI Center recommended approach
Keyword(s):
Keyword(s):
2017 ◽
Vol 58
(2)
◽
pp. 180-192
◽
2011 ◽
pp. 119-131
◽
2020 ◽
Vol 45
(4)
◽
pp. 433-444
Keyword(s):